These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1919075)

  • 21. Simultaneous quantification of zidovudine and its glucuronide in serum by high-performance liquid chromatography.
    Good SS; Reynolds DJ; de Miranda P
    J Chromatogr; 1988 Sep; 431(1):123-33. PubMed ID: 3235523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Approaches to interferon combination therapy in the treatment of AIDS.
    Krown SE
    Semin Oncol; 1990 Feb; 17(1 Suppl 1):11-5; discussion 38-41. PubMed ID: 2405490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of 3'-azido-3'-deoxythymidine and its catabolites and interactions with probenecid in rhesus monkeys.
    Cretton EM; Schinazi RF; McClure HM; Anderson DC; Sommadossi JP
    Antimicrob Agents Chemother; 1991 May; 35(5):801-7. PubMed ID: 1854160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS).
    Kovacs JA; Deyton L; Davey R; Falloon J; Zunich K; Lee D; Metcalf JA; Bigley JW; Sawyer LA; Zoon KC
    Ann Intern Med; 1989 Aug; 111(4):280-7. PubMed ID: 2757312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiretroviral therapy and immunomodulators in patients with AIDS.
    Groopman JE
    Am J Med; 1991 Apr; 90(4A):18S-21S. PubMed ID: 2018046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of AIDS with combinations of antiretroviral agents.
    Merigan TC
    Am J Med; 1991 Apr; 90(4A):8S-17S. PubMed ID: 1850192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extrahepatic metabolism of zidovudine.
    Howe JL; Back DJ; Colbert J
    Br J Clin Pharmacol; 1992 Feb; 33(2):190-2. PubMed ID: 1550699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human recombinant interferon alpha-2a plus 3'-azido-3'-deoxythymidine. Synergistic growth inhibition with evidence of impaired DNA repair in human colon adenocarcinoma cells.
    Darnowski JW; Davol PA; Goulette FA
    Biochem Pharmacol; 1997 Feb; 53(4):571-80. PubMed ID: 9105409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AIDS Clinical Trials Group: phase I/II study of combination 2',3'-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex.
    Meng TC; Fischl MA; Richman DD
    Am J Med; 1990 May; 88(5B):27S-30S. PubMed ID: 2159707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of thymopentin in zidovudine (AZT)-treated asymptomatic HIV-infected subjects with 200-500 CD4 cells/mm3: a double-blind placebo-controlled trial.
    Goldstein G; Conant MA; Beall G; Grossman HA; Galpin JE; Blick G; Calabrese LH; Hirsch RL; Fisher A; Stampone P
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Mar; 8(3):279-88. PubMed ID: 7859140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain targeting of anti-HIV nucleosides: synthesis and in vitro and in vivo studies of dihydropyridine derivatives of 3'-azido-2',3'-dideoxyuridine and 3'-azido-3'-deoxythymidine.
    Chu CK; Bhadti VS; Doshi KJ; Etse JT; Gallo JM; Boudinot FD; Schinazi RF
    J Med Chem; 1990 Aug; 33(8):2188-92. PubMed ID: 2374145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A nonprimate animal model applicable to zidovudine pharmacokinetics in humans: inhibition of glucuronidation and renal excretion of zidovudine by probenecid in rats.
    Mays DC; Dixon KF; Balboa A; Pawluk LJ; Bauer MR; Nawoot S; Gerber N
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1261-70. PubMed ID: 1762074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of zidovudine in HIV-infected patients with end-stage renal disease.
    Kimmel PL; Lew SQ; Umana WO; Li PP; Gordon AM; Straw J
    Blood Purif; 1995; 13(6):340-6. PubMed ID: 8821198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternating and intermittent regimens of zidovudine (3'-azido-3'-deoxythymidine) and dideoxycytidine (2',3'-dideoxycytidine) in the treatment of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.
    Skowron G; Merigan TC
    Am J Med; 1990 May; 88(5B):20S-23S. PubMed ID: 2159705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II, randomized, open-label, community-based trial to compare the safety and activity of combination therapy with recombinant interferon-alpha2b and zidovudine versus zidovudine alone in patients with asymptomatic to mildly symptomatic HIV infection. HIV Protocol C91-253 Study Team.
    Krown SE; Aeppli D; Balfour HH
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Mar; 20(3):245-54. PubMed ID: 10077172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term combined rIFN-alpha-2a and zidovudine therapy for HIV-associated Kaposi's sarcoma: clinical consequences and side effects.
    Stadler R; Bratzke B; Schaart F; Orfanos CE
    J Invest Dermatol; 1990 Dec; 95(6 Suppl):170S-175S. PubMed ID: 2258633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacokinetics of 3'-azido-3 deoxy-thymidine (AZT) in a patient undergoing hemodialysis].
    Deray G; Diquet B; Martinez F; Vidal AM; Petitclerc T; Land G; Raymond F; Baumelou A; Jacobs C
    Therapie; 1989; 44(6):405-8. PubMed ID: 2623654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probenecid inhibits the metabolic and renal clearances of zidovudine (AZT) in human volunteers.
    Hedaya MA; Elmquist WF; Sawchuk RJ
    Pharm Res; 1990 Apr; 7(4):411-7. PubMed ID: 2362917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapy of presymptomatic FeLV-induced immunodeficiency syndrome with AZT in combination with alpha interferon.
    Hoover EA; Zeidner NS; Mullins JI
    Ann N Y Acad Sci; 1990; 616():258-69. PubMed ID: 1964030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.